GE HealthCare awards options and RSUs to executive

Rackliffe Philip reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Rackliffe Philip reported acquisition or exercise transactions in this Form 4 filing.

GE HealthCare Technologies Inc. granted equity awards to executive Philip Rackliffe, CEO of AVS. He received 24,598 employee stock options with a right to buy GE HealthCare common stock and 9,356 restricted stock units, each representing one share upon settlement.

The stock options and restricted stock units vest over three years, with 33% vesting or becoming exercisable on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029. These awards are part of his direct ownership and represent compensation rather than open-market purchases.

Insider Trade Summary

Grant/Award: 33,954 shares

Grant/Award 2 txns

Insider Rackliffe Philip

Role CEO, AVS

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	24,598	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share	9,356	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 24,598 contracts (Direct); Common Stock, par value $0.01 per share — 26,729 shares (Direct)

Footnotes (3)

1. F1. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.
2. F2. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.
3. F3. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the latest Form 4 for GEHC insider Philip Rackliffe report?

The Form 4 reports equity compensation grants to Philip Rackliffe, GE HealthCare’s CEO of AVS. He received 24,598 employee stock options and 9,356 restricted stock units, increasing his directly owned interests in GE HealthCare common stock through awards rather than open-market purchases.

How many stock options did Philip Rackliffe receive from GE HealthCare (GEHC)?

Philip Rackliffe was granted 24,598 employee stock options linked to GE HealthCare common stock. These options give him the right to buy shares in the future, subject to a vesting schedule that begins in 2027 and continues through 2029, aligning incentives over multiple years.

How many restricted stock units (RSUs) were granted to Philip Rackliffe by GEHC?

Philip Rackliffe received 9,356 restricted stock units tied to GE HealthCare common stock. Each unit represents the right to receive one share at settlement. The RSUs vest in three annual tranches from 2027 to 2029, supporting long-term ownership alignment with shareholders.

What is the vesting schedule for Philip Rackliffe’s GE HealthCare equity awards?

Both the stock options and restricted stock units vest over three years. For each award, 33% vest or become exercisable on September 2, 2027, another 33% on September 2, 2028, and the remaining 34% on September 2, 2029, encouraging long-term retention.

Do Philip Rackliffe’s Form 4 transactions in GEHC involve buying or selling shares?

The transactions reflect grants and awards, not open-market buying or selling. The Form 4 shows an acquisition of 24,598 stock options and 9,356 restricted stock units as compensation, classified as “grant, award, or other acquisition,” all held as direct ownership interests.

What does each restricted stock unit granted to Philip Rackliffe represent?

Each restricted stock unit represents the right to receive one share of GE HealthCare common stock at settlement. This means 9,356 RSUs correspond to 9,356 potential future shares, subject to the specified vesting schedule between 2027 and 2029 and continued service conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 04:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rackliffe Philip

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, AVS

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	03/02/2026		A		9,356(1)(2)	A	$0	26,729	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$80.16	03/02/2026		A		24,598		(3)	03/02/2036	Common Stock, par value $0.01 per share	24,598	$0(3)	24,598	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

2. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

3. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.